Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

2010/04/14 by Kazuaki Matsumoto, Ayumi Takeshita, Kazuro Ikawa +6 · 27 citations
Agricultural and Biological Sciences · Medicine · #Adverse effect #Antibiotics Pharmacokinetics and Efficacy #Antimicrobial Resistance in Staphylococcus #Blood urea nitrogen #Creatinine #Drug #Forensic Entomology and Diptera Studies #Gastroenterology #Incidence (geometry) #Internal medicine #Linezolid #Medicine #Pharmacokinetics #Pharmacology #Renal function #Therapeutic drug monitoring #Toxicity #Trough level #Vancomycin

paper · doi:10.1016/j.ijantimicag.2010.02.019

openalex publication_date 2010/04/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure
• Antibiotic Myths for the Infectious Diseases Clinician
• Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. [europepmc]
• Clinical population pharmacokinetics and toxicodynamics of linezolid. [europepmc]
• Risk factors for linezolid-associated thrombocytopenia in adult patients. [europepmc]
• Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment. [europepmc]
• Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials. [europepmc]
• Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact. [europepmc]
• Thrombocytopenia with Tedizolid and Linezolid. [europepmc]
• Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series. [europepmc]
• Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients. [europepmc]
• Real-Life Frequency of New-Onset Thrombocytopenia during Linezolid Treatment. [europepmc]
• A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern Region of Brazil. [europepmc]
• Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis. [europepmc]
• Model Based Identification of Linezolid Exposure-toxicity Thresholds in Hospitalized Patients. [europepmc]
• Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients. [europepmc]
• Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients. [europepmc]
• A Review of Population Pharmacokinetic Analyses of Linezolid. [europepmc]
• Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients. [europepmc]
• New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain. [europepmc]
• Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis. [europepmc]
• Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database. [europepmc]
• Linezolid-Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice. [europepmc]
• Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological Toxicities. [europepmc]
• Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets. [europepmc]
• PK/PD-Guided Strategies for Appropriate Antibiotic Use in the Era of Antimicrobial Resistance. [europepmc]
• Impact of hepatic impairment and renal failure on the pharmacokinetics of linezolid and its metabolites: contribution of hepatic metabolism and renal excretion. [europepmc]